SPATA6
gene geneOn this page
Also known as SRF1FLJ10007SRF-1
Summary
SPATA6 (spermatogenesis associated 6, HGNC:18309) is a protein-coding gene on chromosome 1p33, encoding Spermatogenesis-associated protein 6 (Q9NWH7). Required for formation of the sperm connecting piece during spermiogenesis.
Predicted to enable myosin light chain binding activity. Predicted to be involved in motile cilium assembly and spermatogenesis. Predicted to be located in extracellular region and motile cilium. Predicted to be active in sperm head-tail coupling apparatus.
Source: NCBI Gene 54558 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 90 total
- MANE Select transcript:
NM_019073
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18309 |
| Approved symbol | SPATA6 |
| Name | spermatogenesis associated 6 |
| Location | 1p33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SRF1, FLJ10007, SRF-1 |
| Ensembl gene | ENSG00000132122 |
| Ensembl biotype | protein_coding |
| OMIM | 613947 |
| Entrez | 54558 |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 11 protein_coding, 5 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay
ENST00000371841, ENST00000371843, ENST00000371847, ENST00000396199, ENST00000463938, ENST00000465990, ENST00000471975, ENST00000487543, ENST00000487629, ENST00000490850, ENST00000603831, ENST00000872885, ENST00000872886, ENST00000872887, ENST00000872888, ENST00000930127, ENST00000930128, ENST00000930129
RefSeq mRNA: 3 — MANE Select: NM_019073
NM_001286238, NM_001286239, NM_019073
CCDS: CCDS551, CCDS65535, CCDS72787
Canonical transcript exons
ENST00000371847 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001456309 | 48471958 | 48472204 |
| ENSE00001879864 | 48295373 | 48298893 |
| ENSE00003469234 | 48305787 | 48305878 |
| ENSE00003475782 | 48411464 | 48411588 |
| ENSE00003529978 | 48359586 | 48359770 |
| ENSE00003539829 | 48399351 | 48399644 |
| ENSE00003549610 | 48385309 | 48385349 |
| ENSE00003554099 | 48355670 | 48355769 |
| ENSE00003672133 | 48395267 | 48395354 |
| ENSE00003673588 | 48451552 | 48451600 |
| ENSE00003677392 | 48403802 | 48403882 |
| ENSE00003690597 | 48413110 | 48413151 |
| ENSE00003742261 | 48452994 | 48453131 |
Expression profiles
Bgee: expression breadth ubiquitous, 239 present calls, max score 99.65.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.6425 / max 297.7161, expressed in 1520 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 12256 | 8.8327 | 1491 |
| 12252 | 0.9732 | 479 |
| 12253 | 0.4248 | 231 |
| 12255 | 0.2019 | 77 |
| 12254 | 0.1690 | 82 |
| 12249 | 0.0334 | 5 |
| 12248 | 0.0074 | 3 |
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 99.65 | gold quality |
| male germ cell | CL:0000015 | 98.27 | gold quality |
| left testis | UBERON:0004533 | 97.76 | gold quality |
| right testis | UBERON:0004534 | 97.32 | gold quality |
| sural nerve | UBERON:0015488 | 95.30 | gold quality |
| testis | UBERON:0000473 | 95.29 | gold quality |
| adult organism | UBERON:0007023 | 95.23 | gold quality |
| bronchial epithelial cell | CL:0002328 | 92.13 | gold quality |
| calcaneal tendon | UBERON:0003701 | 91.98 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 90.45 | gold quality |
| right uterine tube | UBERON:0001302 | 88.13 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 86.99 | gold quality |
| tendon | UBERON:0000043 | 86.81 | gold quality |
| tibial nerve | UBERON:0001323 | 86.45 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.98 | gold quality |
| bronchus | UBERON:0002185 | 85.97 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 85.97 | gold quality |
| left ovary | UBERON:0002119 | 83.57 | gold quality |
| colonic epithelium | UBERON:0000397 | 83.17 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.15 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 82.80 | gold quality |
| caput epididymis | UBERON:0004358 | 82.33 | gold quality |
| adrenal tissue | UBERON:0018303 | 82.02 | gold quality |
| corpus callosum | UBERON:0002336 | 81.84 | gold quality |
| tibia | UBERON:0000979 | 81.65 | gold quality |
| right adrenal gland | UBERON:0001233 | 81.49 | gold quality |
| right ovary | UBERON:0002118 | 81.49 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 81.37 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 81.34 | gold quality |
| left adrenal gland | UBERON:0001234 | 81.30 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 31.51 |
| E-ANND-3 | yes | 12.40 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
174 targeting SPATA6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
Literature-anchored findings (GeneRIF, showing 3)
- SPATA6 may play an important role in testicular germ cell tumors, and down-regulation of SPATA6 could lead to apoptosis of testicular germ cell tumors. (PMID:26464655)
- Increased DNA methylation in the spermatogenesis-associated (SPATA) genes correlates with infertility. (PMID:31838782)
- Identification of nonfunctional SPATA20 causing acephalic spermatozoa syndrome in humans. (PMID:36415156)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spata6 | ENSMUSG00000034401 |
| rattus_norvegicus | Spata6 | ENSRNOG00000007568 |
| drosophila_melanogaster | CG14079 | FBGN0036849 |
Paralogs (1): SPATA6L (ENSG00000106686)
Protein
Protein identifiers
Spermatogenesis-associated protein 6 — Q9NWH7 (reviewed: Q9NWH7)
All UniProt accessions (6): Q9NWH7, A0A140VJV1, A8MU33, B1AN51, S4R3R3, S4R3X9
UniProt curated annotations — full annotation on UniProt →
Function. Required for formation of the sperm connecting piece during spermiogenesis. Sperm connecting piece is essential for linking the developing flagellum to the head during late spermiogenesis. May be involved in myosin-based microfilament transport through interaction with myosin subunits.
Subunit / interactions. Interacts with MYL6.
Subcellular location. Secreted. Cell projection. Cilium. Flagellum.
Similarity. Belongs to the SPATA6 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NWH7-1 | 1 | yes |
| Q9NWH7-2 | 2 |
RefSeq proteins (3): NP_001273167, NP_001273168, NP_061946* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032732 | SPATA6_N | Domain |
| IPR042769 | SPATA6_fam | Family |
Pfam: PF14909
UniProt features (24 total): modified residue 11, sequence variant 4, region of interest 2, sequence conflict 2, signal peptide 1, chain 1, glycosylation site 1, cross-link 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NWH7-F1 | 65.12 | 0.23 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (12): 346, 354, 424, 465, 487, 248, 217, 219, 265, 274, 325, 343
Glycosylation sites (1): 181
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 202 (showing top):
AP2_Q3, GOBP_MALE_GAMETE_GENERATION, CAGCTG_AP4_Q5, GOBP_CILIUM_ORGANIZATION, GOBP_ORGANELLE_ASSEMBLY, GNF2_CCNA1, PU1_Q6, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MOTILE_CILIUM_ASSEMBLY, GOBP_CELL_PROJECTION_ORGANIZATION, RGAGGAARY_PU1_Q6, RASHI_RESPONSE_TO_IONIZING_RADIATION_5, AP2_Q6_01, AP2GAMMA_01
GO Biological Process (3): spermatogenesis (GO:0007283), cell differentiation (GO:0030154), motile cilium assembly (GO:0044458)
GO Molecular Function (2): myosin light chain binding (GO:0032027), protein binding (GO:0005515)
GO Cellular Component (5): extracellular region (GO:0005576), motile cilium (GO:0031514), sperm head-tail coupling apparatus (GO:0120212), cilium (GO:0005929), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| cilium assembly | 1 |
| myosin binding | 1 |
| binding | 1 |
| cilium | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
664 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATA6 | SUN5 | Q8TC36 | 749 |
| SPATA6 | SWI5 | Q1ZZU3 | 717 |
| SPATA6 | ODF1 | Q14990 | 707 |
| SPATA6 | OAZ3 | Q9UMX2 | 678 |
| SPATA6 | PMFBP1 | Q8TBY8 | 656 |
| SPATA6 | MEGF10 | Q96KG7 | 631 |
| SPATA6 | TSSK4 | Q6SA08 | 607 |
| SPATA6 | SPATA20 | Q8TB22 | 595 |
| SPATA6 | SPATC1L | Q9H0A9 | 594 |
| SPATA6 | HOOK1 | Q9UJC3 | 587 |
| SPATA6 | SCARF1 | Q14162 | 576 |
| SPATA6 | SPATA18 | Q8TC71 | 563 |
| SPATA6 | DNAH1 | Q9P2D7 | 561 |
| SPATA6 | ROPN1 | Q9HAT0 | 552 |
| SPATA6 | CABYR | O75952 | 526 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPATA6 | DDB2 | psi-mi:“MI:0915”(physical association) | 0.500 |
| SPATA6 | SNX17 | psi-mi:“MI:0914”(association) | 0.350 |
| FTL | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (17): SPATA6 (Affinity Capture-MS), NEDD8-MDP1 (Affinity Capture-MS), DDB2 (Affinity Capture-MS), SPATA6 (Affinity Capture-RNA), SPATA6 (Affinity Capture-MS), SPATA6 (Synthetic Lethality), SPATA6 (Two-hybrid), SPATA6 (Two-hybrid), SPATA6 (Two-hybrid), GEM (Two-hybrid), SPATA6 (Affinity Capture-RNA), C2orf44 (Affinity Capture-MS), IP6K1 (Affinity Capture-MS), WDR83 (Affinity Capture-MS), SNX17 (Affinity Capture-MS)
ESM2 similar proteins: A0JNF3, A3KMW7, A6NFA0, B2RQL2, B2RV46, D3Z8E6, D3ZAP3, D3ZJ47, E9Q309, E9Q793, F5H4B4, O14513, O60303, Q0P5X5, Q1RMQ5, Q2KIP3, Q2KJG1, Q2T9M9, Q32LN6, Q3URK1, Q3V0J4, Q3V0M2, Q53FD0, Q5PQL8, Q5T5Y3, Q642A3, Q68FV5, Q6AYJ3, Q6AYP4, Q6ZVD7, Q7PCK7, Q8BJS7, Q8CB14, Q8CCC3, Q8CCG1, Q8CDL9, Q8K3V1, Q8K3V7, Q8N4H0, Q95LL2
Diamond homologs: B2RV46, Q2KJG1, Q3U6K5, Q6AYJ3, Q8N4H0, Q99MU5, Q9NWH7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
90 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 78 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3179 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:48307216:T:TA | donor_gain | 1.0000 |
| 1:48403782:TTTA:T | donor_gain | 1.0000 |
| 1:48403783:TTAT:T | donor_gain | 1.0000 |
| 1:48403828:T:C | donor_gain | 1.0000 |
| 1:48411462:A:AC | donor_gain | 1.0000 |
| 1:48411463:C:CC | donor_gain | 1.0000 |
| 1:48411463:CT:C | donor_gain | 1.0000 |
| 1:48411585:CCCA:C | acceptor_gain | 1.0000 |
| 1:48411586:CCAC:C | acceptor_gain | 1.0000 |
| 1:48411589:C:CC | acceptor_gain | 1.0000 |
| 1:48451551:CATT:C | donor_gain | 1.0000 |
| 1:48452989:CTCA:C | donor_loss | 1.0000 |
| 1:48452990:TCA:T | donor_loss | 1.0000 |
| 1:48452991:CA:C | donor_loss | 1.0000 |
| 1:48452992:A:AC | donor_gain | 1.0000 |
| 1:48452992:ACCTT:A | donor_loss | 1.0000 |
| 1:48452993:C:CC | donor_gain | 1.0000 |
| 1:48453127:GTTAC:G | acceptor_gain | 1.0000 |
| 1:48453128:TTAC:T | acceptor_gain | 1.0000 |
| 1:48453129:TAC:T | acceptor_gain | 1.0000 |
| 1:48453129:TACC:T | acceptor_loss | 1.0000 |
| 1:48453130:AC:A | acceptor_gain | 1.0000 |
| 1:48453131:CC:C | acceptor_gain | 1.0000 |
| 1:48453132:C:CC | acceptor_gain | 1.0000 |
| 1:48471956:A:AC | donor_gain | 1.0000 |
| 1:48471957:C:CC | donor_gain | 1.0000 |
| 1:48471957:CTGAG:C | donor_gain | 1.0000 |
| 1:48305781:TCATA:T | donor_loss | 0.9900 |
| 1:48305782:CATA:C | donor_loss | 0.9900 |
| 1:48305783:ATAC:A | donor_loss | 0.9900 |
AlphaMissense
3200 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:48403860:A:G | F143S | 1.000 |
| 1:48355719:C:G | R382P | 0.999 |
| 1:48403859:A:C | F143L | 0.999 |
| 1:48403859:A:T | F143L | 0.999 |
| 1:48403861:A:G | F143L | 0.999 |
| 1:48411546:A:G | F108S | 0.999 |
| 1:48413130:A:G | L87S | 0.999 |
| 1:48453000:A:C | F61L | 0.999 |
| 1:48453000:A:T | F61L | 0.999 |
| 1:48453001:A:G | F61S | 0.999 |
| 1:48453002:A:G | F61L | 0.999 |
| 1:48399363:A:C | F256L | 0.998 |
| 1:48399363:A:T | F256L | 0.998 |
| 1:48399365:A:G | F256L | 0.998 |
| 1:48411539:A:C | F110L | 0.998 |
| 1:48411539:A:T | F110L | 0.998 |
| 1:48411541:A:G | F110L | 0.998 |
| 1:48451557:A:G | L78P | 0.998 |
| 1:48453019:A:G | F55S | 0.998 |
| 1:48453085:A:G | L33P | 0.998 |
| 1:48399390:G:C | F247L | 0.997 |
| 1:48399390:G:T | F247L | 0.997 |
| 1:48399392:A:G | F247L | 0.997 |
| 1:48399454:A:G | M226T | 0.997 |
| 1:48399457:C:G | R225P | 0.997 |
| 1:48399459:T:A | R224S | 0.997 |
| 1:48399459:T:G | R224S | 0.997 |
| 1:48403842:A:C | I149S | 0.997 |
| 1:48403866:A:G | L141P | 0.997 |
| 1:48411552:C:G | R106P | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000004079 (1:48286037 C>T), RS1000035303 (1:48286351 T>A), RS1000038163 (1:48368956 G>T), RS1000038505 (1:48440758 A>T), RS1000041328 (1:48360200 G>GA), RS1000044276 (1:48397219 G>A), RS1000050794 (1:48324960 A>G), RS1000105000 (1:48422794 G>A), RS1000106072 (1:48369083 A>T), RS1000111233 (1:48378319 A>G), RS1000111746 (1:48331755 C>T), RS1000115638 (1:48314200 A>C,T), RS1000130964 (1:48394270 A>G), RS1000137398 (1:48300313 G>A,C), RS1000158053 (1:48469670 T>A,C)
Disease associations
OMIM: gene MIM:613947 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008753_1 | Early spontaneous preterm birth | 4.000000e-07 |
| GCST009391_1153 | Metabolite levels | 3.000000e-07 |
| GCST009391_772 | Metabolite levels | 5.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006917 | spontaneous preterm birth |
| EFO:0010459 | aminoadipic acid measurement |
| EFO:0010393 | sphingomyelin 18:0 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases expression | 3 |
| sodium arsenite | decreases expression, affects cotreatment, increases abundance | 2 |
| Nickel | decreases expression | 2 |
| Cadmium Chloride | decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | decreases expression | 1 |
| arsenite | increases methylation | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Arsenic Trioxide | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | affects cotreatment, decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Manganese | affects cotreatment, decreases expression, increases abundance | 1 |
| Phthalic Acids | increases methylation | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.